Safety and efficacy of once-daily didanosine, tenofovir and nevirapine as a simplification antiretroviral approach

MLA

Lidia Ruiz, et al. Safety and Efficacy of Once-Daily Didanosine, Tenofovir and Nevirapine as a Simplification Antiretroviral Approach. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....873c6a1dbd13a58faff917f205198266&authtype=sso&custid=ns315887. Accessed 6 Mar. 2025.

APA

Lidia Ruiz, Eva Rodríguez, Celia Miralles, José Moltó, Sebastià Videla, Carmina R. Fumaz, Bonaventura Clotet, M. José Galindo, Jose A. Muñoz-Moreno, David M. Burger, Pompeyo Viciana, Silvia Gel, Enric Pedrol, Jordi Puig, Eugenia Negredo, & Esteve Ribera. (n.d.). Safety and efficacy of once-daily didanosine, tenofovir and nevirapine as a simplification antiretroviral approach.

Chicago

Lidia Ruiz, Eva Rodríguez, Celia Miralles, José Moltó, Sebastià Videla, Carmina R. Fumaz, Bonaventura Clotet, et al. 2025. “Safety and Efficacy of Once-Daily Didanosine, Tenofovir and Nevirapine as a Simplification Antiretroviral Approach.” Accessed March 6. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....873c6a1dbd13a58faff917f205198266&authtype=sso&custid=ns315887.